The human body generates antibodies after contracting a virus. Scientists have found that some viruses can manifest ADE, meaning antibodies triggered by the first infection could connect the second viral strain to receptors on immune cells—thereby allowing the virus to enter immune cells.
This could potentially trigger a patient who is infected by one strain of a virus to suffer a more serious recurrence of the disease if they are infected by a second strain later on.
Chinese ReportFor an Aug. 30 report, the Yicai news service interviewed four Chinese specialists about the ADE risk from the CCP virus, commonly known as the novel coronavirus.
An unnamed specialist from the Shanghai Public Health Clinical Center said, “Our latest research found out that novel coronavirus has ADE phenomenon, and the percentage is not small.”
Virologist and professor at Hong Kong University Jin Dong-yan also told Yicai that the CCP virus might have ADE. He cited recent cases of recovered patients who later tested positive for COVID-19 again as proof of the phenomenon.
“The patient had antibodies when he was in severe condition [during the second infection], meaning the symptoms might be caused by his immune system. There's the possibility of ADE,” Jin said.
China VaccinesDespite the lack of concrete research, the Chinese regime is moving ahead with COVID-19 vaccine trials. Chinese state-run media Xinhua reported on Aug. 28 that three Chinese companies were performing phase 3 clinical trials, with one manufacturer testing on more than 30,000 people in countries in the Middle East, South America, and Southeast Asia.
U.S.-based China affairs commentator and former medical doctor Tang Jingyuan said the Chinese regime’s push was irresponsible and akin to treating Chinese citizens “as lab mice.”
“The Chinese regime is eager to be the first one to have an approved vaccine. It needs to use the vaccine as a political tool to win the support from developing countries, as well as to compete with the developed countries,” Tang said.
The Yicai report triggered a heated online discussion in China before it was taken down.
“The Chinese regime doesn’t want public opinion to ruin its plan. This is likely the reason why authorities quickly removed the article,” Tang added.